InvestorLens

ASBP — ASPIRE BIOPHARMA HLDGS INC

Public company

Sign in to save1 tracked investor reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ASPIRE BIOPHARMA HLDGS INC (ASBP)

ASPIRE BIOPHARMA HLDGS INC (ASBP) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $1,879. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ASBP

100
/100
Strong Institutional Accumulation
Added / Increased1
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track ASBP

7
/100
Undiscovered
1investor

Only 1 tracked investor report this position.

UndiscoveredCrowded
151015+

ASBP Ownership Composition

How ASPIRE BIOPHARMA HLDGS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Hedge Funds
100% of tracked value
Institutions
1
tracked investors
Total Reported
$1.9K
combined 13F value
Sectors1
  • Hedge Funds100.0%
Hedge Funds(1)
100.0%

Tracked investors reporting ASBP

  • Steve CohenDec 31, 2025
    Point72 Asset Management
    Shares
    14.2K
    Value
    $1.9K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold ASBP?
1 tracked institutional investor disclosed a position in ASBP (ASPIRE BIOPHARMA HLDGS INC) in their most recent 13F filing.
Who is the largest institutional holder of ASBP?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ASBP, valued at $1,879.
Did institutional ownership of ASBP increase or decrease?
Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited ASBP.
Where does this ASBP ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
ASBP (ASPIRE BIOPHARMA HLDGS INC) — Institutional Holders & — InvestorLens